{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:58Z","timestamp":1793047138758,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014978","name":"Hunan University of Chinese Medicine","doi-asserted-by":"publisher","award":["2022XYLH198"],"award-info":[{"award-number":["2022XYLH198"]}],"id":[{"id":"10.13039\/501100014978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ibneur.2025.12.013","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:13:33Z","timestamp":1766794413000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Progress on experimental models of neuromyelitis optica spectrum disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Guo","family":"Yawen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Shunyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Daiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lanxin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Siliang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bpa.12793","article-title":"Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings","volume":"30","author":"Duan","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ibneur.2025.12.013_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103080","article-title":"Asian and African\/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence","volume":"53","author":"Soares-Dos-Reis","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ibneur.2025.12.013_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.msard.2018.12.002","article-title":"Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models","volume":"27","author":"Wu","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.013_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2009.04.004","article-title":"Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica","volume":"9","author":"Saikali","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.ibneur.2025.12.013_bib5","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.013_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.ibneur.2025.12.013_bib7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"issue":"Pt 5","key":"10.1016\/j.ibneur.2025.12.013_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2025.12.013_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.ibneur.2025.12.013_bib11","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1007\/s12035-020-01998-z","article-title":"Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ibneur.2025.12.013_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2016.05.012","article-title":"Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy","volume":"59","author":"Grace","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.013_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26327","article-title":"RGMa Signal in Macrophages Induces Neutrophil-Related Astrocytopathy in NMO","volume":"91","author":"Iwamoto","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2025.12.013_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2377-13-104","article-title":"Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis","volume":"13","author":"Saini","year":"2013","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","article-title":"Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica","volume":"62","author":"Ratelade","year":"2014","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12974-021-02232-w","article-title":"Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats","volume":"18","author":"Ishikura","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ibneur.2025.12.013_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","article-title":"Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59","volume":"53","author":"Zhang","year":"2014","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41598-017-18362-2","article-title":"Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica","volume":"8","author":"Harada","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.12.013_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-11-16","article-title":"Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G","volume":"11","author":"Asavapanumas","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-016-0577-8","article-title":"Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid","volume":"13","author":"Marignier","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ibneur.2025.12.013_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.msard.2019.02.025","article-title":"Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice","volume":"30","author":"Lee","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ibneur.2025.12.013_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exer.2013.12.010","article-title":"Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve","volume":"119","author":"Matsumoto","year":"2014","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.ibneur.2025.12.013_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.exer.2018.06.011","article-title":"Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis","volume":"175","author":"Zhang","year":"2018","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.ibneur.2025.12.013_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2051-5960-1-5","article-title":"Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats","volume":"1","author":"Kitic","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.ibneur.2025.12.013_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015050","article-title":"Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica","volume":"5","author":"Nelson","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ibneur.2025.12.013_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00401-015-1501-5","article-title":"Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS","volume":"130","author":"Zeka","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ibneur.2025.12.013_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-015-0207-1","article-title":"Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica","volume":"3","author":"Jones","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016083","article-title":"Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica","volume":"6","author":"Kalluri","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.013_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"51","key":"10.1016\/j.ibneur.2025.12.013_bib31","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1073\/pnas.1617859114","article-title":"Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4","volume":"113","author":"Sagan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.ibneur.2025.12.013_bib32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ibneur.2025.12.013_bib33","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice","volume":"116","author":"Bettelli","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.ibneur.2025.12.013_bib34","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1172\/JCI28330","article-title":"Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell\/B cell cooperation","volume":"116","author":"Krishnamoorthy","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.ibneur.2025.12.013_bib35","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.ymthe.2023.07.017","article-title":"Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases","volume":"31","author":"Xu","year":"2023","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.ibneur.2025.12.013_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12264-015-1552-6","article-title":"Experimental models of neuromyelitis optica: current status, challenges and future directions","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"issue":"6","key":"10.1016\/j.ibneur.2025.12.013_bib37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.013_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-016-0309-4","article-title":"Clobetasol promotes remyelination in a mouse model of neuromyelitis optica","volume":"4","author":"Yao","year":"2016","journal-title":"Acta Neuropathol. Commun."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:21:58Z","timestamp":1782159718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2667242125002052"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.12.013","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress on experimental models of neuromyelitis optica spectrum disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}